INBIOS INTERNATIONAL INC: contratos federales ganados
Contratos federales de 10.000 USD o más adjudicados a esta empresa desde octubre de 2020 (AF 2021), según USAspending.gov. UEI: CNJNQ1GMSN55
12contratos ganados
$127,208,173total comprometido
$3,276,734contrato mediano
20 abr 2026inicio más reciente
Agencias para las que trabaja
| Agencia | Contratos | Comprometido |
|---|---|---|
| Department of Defense | 5 | $90,971,573 |
| Department of Health and Human Services | 7 | $36,236,601 |
Industrias (NAICS)
| NAICS | Contratos | Comprometido |
|---|---|---|
| 325413 Fabricación de sustancias para diagnóstico in vitro | 4 | $75,394,258 |
| 541711 Research and development in biotechnology | 4 | $37,032,173 |
| 541715 Investigación y desarrollo en ciencias físicas, ingeniería y ciencias de la vida (excepto nanotecnología y biotecnología) | 2 | $13,631,879 |
| 541714 Investigación y desarrollo en biotecnología (excepto nanobiotecnología) | 2 | $1,149,864 |
Dónde trabaja
Contratos recientes
| Contrato | Ganador | Agencia | Comprometido | Inicio |
|---|---|---|---|---|
| INBIOS REAGENTS KITS
75D30126P20991 · NAICS 325413 Fabricación de sustancias para diagnóstico in vitro · San Juan, PR |
— | Department of Health and Human Services Centers for Disease Control and Prevention |
$62,258 | 20 abr 2026 Fin: 19 sep 2026 |
| TOPIC 455: DEVELOPMENT OF A RAPID AT-HOME TEST TO DETECT PROSTATE-SPECIFIC ANTIGEN USING SELF-COLLECTED FINGER STICKBLOOD
75N91024C00078 · NAICS 541714 Investigación y desarrollo en biotecnología (excepto nanobiotecnología) · Seattle, WA |
— | Department of Health and Human Services National Institutes of Health |
$399,866 Valor potencial: $454,183 |
16 sep 2024 Fin: 15 sep 2025 |
| OVER THE COUNTER (OTC) COVID-19 TESTS
75A50223C00041 · NAICS 325413 Fabricación de sustancias para diagnóstico in vitro · Seattle, WA |
— | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response |
$20,736,000 | 20 sep 2023 Fin: 19 mar 2025 |
| THE PURPOSE OF THIS CONTRACT IS TO PROCURE OVER THE COUNTER (OTC) COVID-19 TESTS.
75A50223C00003 · NAICS 325413 Fabricación de sustancias para diagnóstico in vitro · Seattle, WA |
— | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response |
$2,596,000 | 7 dic 2022 Fin: 15 feb 2023 |
| COVID-19 OTC TEST KIT
W58P0522C0014 · NAICS 325413 Fabricación de sustancias para diagnóstico in vitro · Seattle, WA |
— | Department of Defense Department of the Army |
$52,000,000 | 17 feb 2022 Fin: 9 sep 2022 |
| COVID-19 - DHHS/BARDA - INBIOS INTERNATIONAL, INC. PRODUCTION CAPACITY EXPANSION - ACTION AWARDED UNDER CSO FA7013-20-S-0002
FA865621C8877 · NAICS 541715 Investigación y desarrollo en ciencias físicas, ingeniería y ciencias de la vida (excepto nanotecnología y biotecnología) · Seattle, WA |
— | Department of Defense Department of the Air Force |
$12,670,301 | 30 oct 2020 Fin: 30 jun 2021 |
| MEDICAL RESEARCH AND DEVELOPMENT CONTRACT ARMY SBIR SEQ PH PROPOSAL NO. A28137 TOPIC A14049 TITLE DIAGNOSTIC DEVICE FOR NOROVIRUS GASTROENT…
W81XWH20C0071 · NAICS 541715 Investigación y desarrollo en ciencias físicas, ingeniería y ciencias de la vida (excepto nanotecnología y biotecnología) · Seattle, WA |
— | Department of Defense Department of the Army |
$961,577 | 23 sep 2020 Fin: 22 ene 2023 |
| COVID-19-FDA EUA ANTIGEN DETECTION- FDA FAST TRACK SEROLOGY ASSAY OPTIMIZATION
W81XWH20F0253 · NAICS 541711 Research and development in biotechnology · Seattle, WA |
— | Department of Defense Defense Health Agency |
$24,533,391 Valor potencial: $25,655,995 |
15 jun 2020 Fin: 31 may 2025 |
| COVID-19 -- INBIOS R&D OF AN ANTIBODY DIAGNOSTIC
75A50120C00090 · NAICS 541714 Investigación y desarrollo en biotecnología (excepto nanobiotecnología) · Seattle, WA |
— | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response |
$749,998 | 24 abr 2020 Fin: 1 oct 2021 |
| OTHER DIRECT COST
W81XWH19F0423 · NAICS 541711 Research and development in biotechnology · Seattle, WA |
— | Department of Defense Department of the Army |
$806,303 | 22 jul 2019 Fin: 21 jun 2021 |
| IGF::OT::IGF - BASE PERIOD AWARD TO INBIOS INTERNATIONAL, INC. FOR POINT-OF-CARE IMMUNOASSAY FOR DIAGNOSIS OF INHALATIONAL ANTHRAX
HHSO100201700029C · NAICS 541711 Research and development in biotechnology · Seattle, WA |
— | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response |
$3,957,468 Valor potencial: $12,051,614 |
26 sep 2017 Fin: 30 sep 2027 |
| IGF::OT::IGF INBIOS - DEVELOPMENT OF POINT-OF-CARE ANDLABORATORY-BASED IMMUNOASSAYS FOR PRESUMPTIVE DIAGNOSIS OF ZIKA VIRUS INFECTION
HHSO100201600014C · NAICS 541711 Research and development in biotechnology · Seattle, WA |
— | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response |
$7,735,011 | 27 jul 2016 Fin: 31 dic 2023 |
Fuente: USAspending.gov (contratos principales de 10.000 USD o más). Los valores son lo comprometido hasta hoy. Los meses recientes aún pueden cambiar porque las agencias reportan con retraso.